tiprankstipranks
Immunogen (IMGN)
NASDAQ:IMGN
Holding IMGN?
Track your performance easily

ImmunoGen (IMGN) Cash flow

1,265 Followers

ImmunoGen Cash Flow

IMGN's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, IMGN's free cash flow was decreased by $-60.32M and operating cash flow was $2.77M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -199.71M$ -229.80M$ -169.42M$ -78.62M$ -88.37M$ -166.42M
Investing Cash Flow
$ -77.00K$ -1.36M$ -1.43M$ 509.00K$ -533.00K$ -5.25M
Financing Cash Flow
$ 495.80M$ 27.55M$ 355.74M$ 195.74M$ 2.87M$ 166.81M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 857.39M$ 275.18M$ 478.74M$ 293.86M$ 176.22M$ 262.25M
Income Tax Paid Supplemental Data
$ 1.36M-----
Interest Paid Supplemental Data
$ 4.86M-$ 47.00K$ 95.00K$ 95.00K$ 95.00K
Issuance Of Capital Stock
$ 376.45M$ 25.65M$ 154.03M$ 194.27M$ 0.00$ 162.51M
Issuance Of Debt
$ 71.82M-$ -1.10M--$ 0.00
Repayment Of Debt
--$ -1.10M$ 0.00--
Free Cash Flow
$ -203.02M$ -231.17M$ -170.85M$ -79.54M$ -91.21M$ -171.67M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ImmunoGen Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis